Back to Search
Start Over
Optimal dose of losartan for renoprotection in diabetic nephropathy.
- Source :
- Nephrology Dialysis Transplantation; Aug2002, Vol. 17 Issue 8, p1413-1418, 6p
- Publication Year :
- 2002
-
Abstract
- Background. Angiotensin II subtype‐1 receptor antagonists represent a valuable new class of drugs in the treatment of diabetic nephropathy. The aim of our study was to evaluate the optimal dose of losartan for renoprotection and blood pressure reduction in diabetic nephropathy. [ABSTRACT FROM PUBLISHER]
Details
- Language :
- English
- ISSN :
- 09310509
- Volume :
- 17
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Nephrology Dialysis Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 44430412
- Full Text :
- https://doi.org/10.1093/ndt/17.8.1413